pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,025 catalysts · 7,021 phase readout · 2,432 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 3 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: adcom×type: pdufa×clear all
type
  • phase readout7,021
  • 8k filing2,432
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›WITHHELDphase readoutNCT04136158: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›RECRUITINGphase readoutNCT06971848: Evaluation of Skin Tests in Biotherapy Allergies

Sponsor: University Hospital, Angers. Phase: NA. Conditions: Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Melanoma Neoplasms, Small Cell Bronchial Carcinomas, Bronchial Carcinoma, Pleural Mesothelioma, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Myeloma, AL Amyloidosis, Hepatocarcinoma, Colorectal Cancer, Esophageal Squamous Cell Carcinoma, Heart Cancer, Cholangiocarcinoma, Colorectal Adenocarcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07601555: Body Composition, Functional Capacity, and Respiratory Muscle Endurance in Obesity With Restrictive Ventilatory Pattern

Sponsor: Biruni University. Phase: . Conditions: Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT04923126: SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Sponsor: St. Jude Children's Research Hospital. Phase: PHASE1. Conditions: Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06375226: Autism and Attachment. An Explorative Study of Attachment Styles in Autistic Adults.

Sponsor: Parnassia Groep. Phase: . Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04024943: Personalized Therapy Study - Attain Stability Quad Post-Approval Study

Sponsor: Medtronic. Phase: . Conditions: Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07598643: Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1

Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Down Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07352943: Development of a Mindfulness-Based Smartphone Application for BMT Caregivers

Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: NA. Conditions: Caregivers of Hematopoietic Stem Cell Transplant (HCT) Patients

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07045415: The Effect of Pelvic Floor Muscle Exercises After Radical Prostatectomy

Sponsor: KTO Karatay University. Phase: NA. Conditions: Prostate Cancer (Post Prostatectomy), Urinary Incontinence (UI)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06626035: Evaluation of Analgesia for Cardiac Elective Surgery in Children

Sponsor: Senthil Sadhasivam. Phase: PHASE3. Conditions: Pediatric Cardiac Surgery

full page →ctgov ↗
›COMPLETEDphase readoutNCT06339125: Predictive Analytics and Computer Visualization Enhances Patient Safety to Prevent Falls

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Fall Patients, Fall Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07410325: Effectiveness and Implementation of a Community-based Health Coach-led Artificial Intelligence (AI)-Powered Digital Self-Regulation Program for Individuals With Metabolic Syndrome (MetS)

Sponsor: National University Health System, Singapore. Phase: NA. Conditions: Metabolic Syndrome (MetS), Metabolic Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT05446376: Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis

Sponsor: University Hospital, Bordeaux. Phase: PHASE2. Conditions: Infective Endocarditis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07520617: Evaluation of the ADD'Pro Vocational Reintegration Program (ADD-PRO-EVAL)

Sponsor: University Hospital, Clermont-Ferrand. Phase: NA. Conditions: Addiction, Addiction Disorders, Substance Use Recovery, Return to Work, Recovery, Recovery Outcomes, Substance Use Disorder (SUD), Employment, Supported, Employment, Substance Related Disorders, Vocational Rehabilitation, Substance Use (Drugs, Alcohol)

full page →ctgov ↗
›COMPLETEDphase readoutNCT02076217: Quick Start of Highly Effective Contraception

Sponsor: University of Utah. Phase: . Conditions: IUD, Contraceptive Implant, Contraception, Birth Control, Emergency Contraception

full page →ctgov ↗
›COMPLETEDphase readoutNCT07580417: Tongue Postural Training in Text Related Neck Syndrome

Sponsor: Elite College of Management Sciences, Gujranwala, Pakistan. Phase: NA. Conditions: Neck Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT05723250: Care Coordination Educational Intervention Study for Patients From Rural Areas With Early Stage Cancer

Sponsor: University of Vermont Medical Center. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06160791: Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

Sponsor: Jerry Lee, MD, MSc, MPhil. Phase: PHASE2. Conditions: Hemophagocytic Lymphohistiocytoses

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07162350: Food as Medicine Study

Sponsor: Parkland Health and Hospital System. Phase: NA. Conditions: Chronic Diseases in Children

full page →ctgov ↗
›RECRUITINGphase readoutNCT06966791: Sexual Functıon in Young Women After Breast Cancer Surgery

Sponsor: ATİYE KAŞ ÖZDEMİR. Phase: . Conditions: Breast Cancer Surgery, Young Adult Females

full page →ctgov ↗
›COMPLETEDphase readoutNCT06628791: BK329 and Body Fat Reduction

Sponsor: Pusan National University Yangsan Hospital. Phase: NA. Conditions: Obesity and Overweight

full page →ctgov ↗
›RECRUITINGphase readoutNCT07360418: Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.

Sponsor: Applied Biologics, LLC. Phase: . Conditions: Diabetic Foot Ulcers (DFU), Foot Ulcer Chronic, Ulcer, Diabetic Foot Ulcer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05677997: Evaluating the Impact of Resource Navigators to Support LTC and RH Staff During and Beyond COVID-19

Sponsor: Unity Health Toronto. Phase: NA. Conditions: Wellness, Burnout, Caregiver, Burnout, Professional, COVID-19, Vaccine Refusal

full page →ctgov ↗
›RECRUITINGphase readoutNCT07578610: Biomedical Signal Extraction From Symptom Descriptions: An Observational Registry Using the OpenGenome Platform

Sponsor: OpenGenome. Phase: . Conditions: Signs and Symptoms, Fever, Myalgia, Skin Diseases, Hemorrhagic Fever With Renal Syndrome, Zoonoses

full page →ctgov ↗
›RECRUITINGphase readoutNCT03854110: A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine

Sponsor: Persevere Therapeutics Inc.. Phase: PHASE1. Conditions: Ovarian Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03395210: A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Sponsor: Principia Biopharma, a Sanofi Company. Phase: PHASE2. Conditions: Immune Thrombocytopenia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06689410: Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Aneurysm, Brain Aneurysm, Congenital Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05696613: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

Sponsor: Cerium Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Primary Membranous Nephropathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06570213: Evaluating The Efficacy Of Combined Cognitive Processing Therapy and Stellate Ganglion Blocks for PTSD

Sponsor: Rush University Medical Center. Phase: EARLY_PHASE1. Conditions: PTSD

full page →ctgov ↗
›COMPLETEDphase readoutNCT05651360: Diagnostic Performance of Low-Dose CT for Acute Abdominal Conditions

Sponsor: Oslo University Hospital. Phase: . Conditions: Abdominal Pain, Acute Pain, Acute Cholecystitis, Acute Appendicitis, Acute Pancreatitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07391020: Text Message Safety Behavior Fading for Pathological Worry

Sponsor: Florida State University. Phase: NA. Conditions: Generalized Anxiety Disorder (GAD), Worrying, Anxiety

full page →ctgov ↗
›COMPLETEDphase readoutNCT06695130: Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

Sponsor: Sanofi. Phase: PHASE1. Conditions: COVID-19 Immunization, Influenza Immunization

full page →ctgov ↗
›RECRUITINGphase readoutNCT05777330: Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes

Sponsor: Universitair Ziekenhuis Brussel. Phase: NA. Conditions: Type1 Diabetes Mellitus

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05035030: Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

Sponsor: Albireo, an Ipsen Company. Phase: PHASE3. Conditions: Alagille Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07742228: SCENAR Therapy in Chronic Non-specific Neck Pain

Sponsor: Hopital Foch. Phase: NA. Conditions: Cervicalgia, Neck Pain, Chronic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT03958565: Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

Sponsor: University of Colorado, Denver. Phase: . Conditions: Carcinoma, Non-Small-Cell Lung

full page →ctgov ↗
›RECRUITINGphase readoutNCT06214065: Modulating Temporoparietal Junction Mentalizing-Related Activity in Autism Spectrum Disorder (ASD) Using Transcranial Magnetic Stimulation (TMS)

Sponsor: Yale University. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06951867: Tezspire Cardiac Events PASS

Sponsor: AstraZeneca. Phase: . Conditions: Cardiovascular Events, MACE

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03319667: A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Sponsor: Sanofi. Phase: PHASE3. Conditions: Plasma Cell Myeloma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05961267: Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism

Sponsor: University Hospital, Bordeaux. Phase: . Conditions: Arthritis, Rheumatoid, Spondylitis, Ankylosing, Lupus Erythematosus, Systemic, Scleroderma, Systemic, Sjogren's Syndrome, Mixed Connective Tissue Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06680167: Hyperbaric Prilocaine 2% vs Hyperbaric Bupivacaine 0.5% in Caesarean Section

Sponsor: Sohag University. Phase: EARLY_PHASE1. Conditions: Spinal Anesthesia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06164600: Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children

Sponsor: Ain Shams University. Phase: PHASE2. Conditions: Urinary Tract Infections, Recurrent, Child, Prevention & Control, Infections, Urologic Diseases, Communicable Diseases

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00590200: GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease

Sponsor: The Cleveland Clinic. Phase: . Conditions: Cardiovascular Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07281300: Mindfulness-Oriented Respiratory Distress Symptom Intervention for Lung Cancer

Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Symptom Cluster, Breathlessness, Coughing, Fatigue Symptom, Lung Cancer Patients, Brain Activity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06371300: Photobiomodulation With REd vs BluE Light (REBEL)

Sponsor: Aston University. Phase: NA. Conditions: Dry Eye Syndromes, Meibomian Gland Dysfunction, Blepharitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04997200: Effect of Sleep Deprivation on Breathlessness and Exercise Capacity in COPD

Sponsor: Skane University Hospital. Phase: NA. Conditions: COPD

full page →ctgov ↗
›TERMINATEDphase readoutNCT06021600: A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Leukemia, Myelodysplastic Syndromes, Acute Myeloid Leukemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07457307: Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac

Sponsor: NYU Langone Health. Phase: PHASE1. Conditions: High-grade Glioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07014592: Characterization and Analysis of Evoked Cortical Responses in Participants With Medication-intractable Epilepsy

Sponsor: University of Michigan. Phase: NA. Conditions: Intractable Epilepsy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07187336: The Efficacy and Safety of Shoulder Motion Style Acupuncture Treatment (MSAT) on in Patients With Shoulder Pain Caused by Traffic Accidents

Sponsor: Jaseng Medical Foundation. Phase: NA. Conditions: Shoulder Pain

full page →ctgov ↗
← prev
page 139 of 141
next →